Antithrombin III Milano 2: a single base substitution in the thrombin binding domain detected with PCR and direct genomic sequencing.
作者信息
Olds R J, Lane D, Caso R, Tripodi A, Mannucci P M, Thein S L
机构信息
Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.
出版信息
Nucleic Acids Res. 1989 Dec 25;17(24):10511. doi: 10.1093/nar/17.24.10511.
Abstract
摘要
相似文献
1
Antithrombin III Milano 2: a single base substitution in the thrombin binding domain detected with PCR and direct genomic sequencing.抗凝血酶III米兰2型：通过聚合酶链反应（PCR）和直接基因组测序检测到凝血酶结合域中的单个碱基替换。
Nucleic Acids Res. 1989 Dec 25;17(24):10511. doi: 10.1093/nar/17.24.10511.
2
Antithrombin III Sudbury: an Ala384----Pro mutation with abnormal thrombin-binding activity and thrombotic diathesis.
Thromb Res. 1990 Aug 15;59(4):793-7. doi: 10.1016/0049-3848(90)90061-g.
3
Antithrombin III Padua 2: a single base substitution in exon 2 detected with PCR and direct genomic sequencing.
Nucleic Acids Res. 1990 Apr 11;18(7):1926. doi: 10.1093/nar/18.7.1926.
4
Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.
Thromb Haemost. 1986 Dec 15;56(3):349-52.
5
6
Antithrombin III-Amiens: a new family with an Arg47----Cys inherited variant of antithrombin III with impaired heparin cofactor activity.
Am J Hematol. 1991 Jan;36(1):25-9. doi: 10.1002/ajh.2830360106.
7
8
The N-terminal domain of antithrombin-III is essential for heparin binding and complex-formation with, but not cleavage by, alpha-thrombin.抗凝血酶III的N端结构域对于与α-凝血酶结合肝素及形成复合物至关重要，但对于α-凝血酶的裂解并非如此。
Biochem J. 1992 Mar 1;282 ( Pt 2)(Pt 2):345-51. doi: 10.1042/bj2820345.
9
Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.凝血酶结合受损的遗传性异常抗凝血酶III的纯化与特性分析
J Lab Clin Med. 1984 Aug;104(2):245-56.
10
The molecular pathology of inherited human antithrombin III deficiency.
Transfus Med Rev. 1989 Oct;3(4):264-81. doi: 10.1016/s0887-7963(89)70087-0.
引用本文的文献
1
Missense mutation of (p.Ser426Leu) in a young patient presenting as refractory and recurrent venous thromboembolism: A case report.一名表现为难治性复发性静脉血栓栓塞的年轻患者中 （p.Ser426Leu） 的错义突变：病例报告
Front Cardiovasc Med. 2022 Aug 24;9:903785. doi: 10.3389/fcvm.2022.903785. eCollection 2022.
2
Whole-exome sequencing in evaluation of patients with venous thromboembolism.全外显子组测序在静脉血栓栓塞症患者评估中的应用
Blood Adv. 2017 Jun 29;1(16):1224-1237. doi: 10.1182/bloodadvances.2017005249. eCollection 2017 Jul 11.
3
Whole Exome Sequencing Reveals Severe Thrombophilia in Acute Unprovoked Idiopathic Fatal Pulmonary Embolism.全外显子组测序揭示急性无诱因特发性致死性肺栓塞中的严重血栓形成倾向。
EBioMedicine. 2017 Mar;17:95-100. doi: 10.1016/j.ebiom.2017.01.037. Epub 2017 Jan 31.
4
Three novel missense mutations in the antithrombin III (AT3) gene causing recurrent venous thrombosis.抗凝血酶III（AT3）基因中的三个新错义突变导致复发性静脉血栓形成。
Hum Genet. 1994 Nov;94(5):509-12. doi: 10.1007/BF00211016.
5
Antithrombin III: summary of first database update.抗凝血酶III：首个数据库更新总结
Nucleic Acids Res. 1994 Sep;22(17):3556-9.
6
Pleiotropic effects of antithrombin strand 1C substitution mutations.抗凝血酶1C链替代突变的多效性作用
J Clin Invest. 1992 Dec;90(6):2422-33. doi: 10.1172/JCI116133.
本文引用的文献
1
The covalent nature of the human antithrombin III--thrombin bond.人抗凝血酶III与凝血酶键的共价性质。
Biochem J. 1980 Sep 1;189(3):481-9. doi: 10.1042/bj1890481.
2
Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.
Thromb Haemost. 1986 Dec 15;56(3):349-52.
3
Site-directed mutagenesis of the reactive center (serine 394) of antithrombin III.抗凝血酶III反应中心（丝氨酸394）的定点诱变。
J Biol Chem. 1988 Nov 5;263(31):15849-52.
Zotero 插件